{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:58:57Z","timestamp":1781632737806,"version":"3.54.5"},"reference-count":22,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Hallym University Research Fund","award":["HURF-2024-30"],"award-info":[{"award-number":["HURF-2024-30"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"\n Purpose<\/jats:title>\n The goal of antiretroviral therapy is to achieve and sustain the suppression of human immunodeficiency virus (HIV) viral load. In this study, we aimed to identify risk factors for low-level viremia (LLV) and examine their association with clinical outcomes in South Korea.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n We retrospectively reviewed the medical records of patients with human immunodeficiency virus infection registered at Seoul Medical Center and Hallym University Sacred Heart Hospital between 2014 and 2023. LLV was defined as at least two consecutive HIV RNA measurements of 40\u2013199 copies\/mL taken more than 4 weeks apart. Patients with LLV were compared with those who maintained virological suppression (viral load\u2009<\u200940 copies\/mL).<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Of the 381 patients included in the analysis, 15 (3.94%) experienced LLV. Compared with patients who maintained virological suppression, patients with LLV more frequently had an initial viral load\u2009\u2265\u2009500,000 copies\/mL (\n P<\/jats:italic>\n \u2009<\u20090.01). No significant differences were observed between the groups in the rates of virological rebound, new-onset acquired immune deficiency syndrome\u2013defining conditions, or mortality. Multivariable logistic regression identified an initial viral load\u2009\u2265\u2009500,000 copies\/mL as an independent risk factor for LLV (adjusted odds ratio, 4.735; 95% confidence interval, 1.505\u201314.897).\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n A high viral load was a significant risk factor for LLV. Large multicenter studies are required to further investigate risk factors and clinical implications of LLV in people living with HIV.<\/jats:p>\n <\/jats:sec>","DOI":"10.1371\/journal.pone.0350391","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:33:11Z","timestamp":1781631191000},"page":"e0350391","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Factors associated with low-level viremia in people living with HIV: A 10-year retrospective study in South Korea"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5337-9830","authenticated-orcid":true,"given":"Eunmi","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0310-0408","authenticated-orcid":true,"given":"Subin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8661-8316","authenticated-orcid":true,"given":"Doh Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi Young","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Phil","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,6,16]]},"reference":[{"issue":"13","key":"pone.0350391.ref001","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators","volume":"338","author":"FJ Palella","year":"1998","journal-title":"N Engl J Med"},{"key":"pone.0350391.ref002","volume-title":"Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV","author":"Panel on Antiretroviral Guidelines for Adults and Adolescents","year":"2023"},{"issue":"7","key":"pone.0350391.ref003","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1001\/jama.293.7.817","article-title":"Intermittent HIV-1 viremia (Blips) and drug resistance in patients receiving HAART","volume":"293","author":"RE Nettles","year":"2005","journal-title":"JAMA"},{"issue":"2","key":"pone.0350391.ref004","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1001\/jama.286.2.171","article-title":"Prevalence and predictive value of intermittent viremia with combination hiv therapy","volume":"286","author":"DV Havlir","year":"2001","journal-title":"JAMA"},{"issue":"6","key":"pone.0350391.ref005","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1097\/MS9.0000000000003272","article-title":"Impact of low-level viremia on HIV non-viral load suppression in low and middle-income countries","volume":"87","author":"JV Mbishi","year":"2025","journal-title":"Ann Med Surg (Lond)"},{"key":"pone.0350391.ref006","doi-asserted-by":"crossref","first-page":"1661253","DOI":"10.3389\/fpubh.2025.1661253","article-title":"Prevalence of low-level viremia and related influencing factors among people living with HIV in China: a systematic review and meta-analysis","volume":"13","author":"X Zhang","year":"2025","journal-title":"Front Public Health"},{"key":"pone.0350391.ref007","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.2147\/PPA.S207908","article-title":"Treatment adherence and persistence among HIV-1 patients newly starting treatment","volume":"13","author":"DM Hines","year":"2019","journal-title":"Patient Prefer Adherence"},{"issue":"6","key":"pone.0350391.ref008","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/aje\/kwq433","article-title":"Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries","volume":"173","author":"H Quan","year":"2011","journal-title":"Am J Epidemiol"},{"issue":"3","key":"pone.0350391.ref009","article-title":"Revised surveillance case definition for HIV infection \u2014 United States, 2014","volume":"63","author":"JS Moran","year":"2014","journal-title":"MMWR"},{"issue":"5","key":"pone.0350391.ref010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0268540","article-title":"Factors associated with low-level viraemia in people with HIV starting antiretroviral therapy: a Swedish observational study","volume":"17","author":"H Brattg\u00e5rd","year":"2022","journal-title":"PLoS One"},{"issue":"1","key":"pone.0350391.ref011","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12879-020-4837-y","article-title":"Factors associated with high-risk low-level viremia leading to virologic failure: 16-year retrospective study of a Chinese antiretroviral therapy cohort","volume":"20","author":"T Zhang","year":"2020","journal-title":"BMC Infect Dis"},{"issue":"1","key":"pone.0350391.ref012","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1186\/s12916-025-04166-z","article-title":"Low-level viremia increases the risk of diabetes mellitus in people with HIV in China: a 7-year retrospective longitudinal cohort study","volume":"23","author":"C Tao","year":"2025","journal-title":"BMC Med"},{"issue":"3","key":"pone.0350391.ref013","doi-asserted-by":"crossref","first-page":"250","DOI":"10.2174\/1570162X13666150407142539","article-title":"HIV replication at low copy number and its correlation with the HIV reservoir: a clinical perspective","volume":"13","author":"L Sarmati","year":"2015","journal-title":"Curr HIV Res"},{"issue":"1","key":"pone.0350391.ref014","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1080\/21505594.2021.2004743","article-title":"Persistent low-Level viremia in persons living with HIV undertreatment: an unresolved status","volume":"12","author":"C Crespo-Bermejo","year":"2021","journal-title":"Virulence"},{"issue":"1","key":"pone.0350391.ref015","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1038\/s41467-019-10884-9","article-title":"Determinants of HIV-1 reservoir size and long-term dynamics during suppressive ART","volume":"10","author":"N Bachmann","year":"2019","journal-title":"Nat Commun"},{"issue":"10","key":"pone.0350391.ref016","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1093\/cid\/cit529","article-title":"Virologic failure following persistent low-level viremia in a cohort of HIV-positive patients: results from 12 years of observation","volume":"57","author":"C Laprise","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"3","key":"pone.0350391.ref017","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/QAD.0000000000000544","article-title":"Impact of low-level viremia on clinical and virological outcomes in treated HIV-1-infected patients","volume":"29","author":"Antiretroviral Therapy Cohort Collaboration (ART-CC)","year":"2015","journal-title":"AIDS"},{"key":"pone.0350391.ref018","doi-asserted-by":"crossref","first-page":"939261","DOI":"10.3389\/fmed.2022.939261","article-title":"The impact of low-level viraemia on virological failure-results from a multicenter HIV antiretroviral therapy cohort study in Yunnan, China","volume":"9","author":"J An","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"3","key":"pone.0350391.ref019","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/QAI.0000000000001678","article-title":"Low-level viremia is associated with clinical progression in HIV-infected patients receiving antiretroviral treatment","volume":"78","author":"E Bernal","year":"2018","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"9","key":"pone.0350391.ref020","doi-asserted-by":"crossref","DOI":"10.1016\/S2352-3018(16)30016-9","article-title":"Integrase inhibitor versus protease inhibitor based regimen for HIV-1 infected women (WAVES): a randomised, controlled, double-blind, phase 3 study","volume":"3","author":"K Squires","year":"2016","journal-title":"Lancet HIV"},{"issue":"3","key":"pone.0350391.ref021","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/QAI.0000000000002275","article-title":"Durable efficacy of dolutegravir plus lamivudine in antiretroviral treatment-naive adults with HIV-1 infection: 96-week results from the GEMINI-1 and GEMINI-2 randomized clinical trials","volume":"83","author":"P Cahn","year":"2020","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"pone.0350391.ref022","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/hiv.13593","article-title":"Twelve-month effectiveness and safety of bictegravir\/emtricitabine\/tenofovir alafenamide in people with HIV: real-world insights from BICSTaR cohorts","volume":"25","author":"S Esser","year":"2024","journal-title":"HIV Med"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0350391","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:33:17Z","timestamp":1781631197000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0350391"}},"subtitle":[],"editor":[{"given":"Graciela","family":"Andrei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":22,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0350391","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,16]]}}}